Pharma channel feed

Medi­Wound’s US launch of its top­i­cal gel for burns de­layed to Q1 due to man­u­fac­tur­ing ‘de­vi­a­tion’

Last year

Ama­zon Phar­ma­cy de­liv­ers in­sulin dis­counts in new au­to­mat­ic coupon pro­gram

Last year

Bio­con fa­cil­i­ty in Malaysia found to have is­sues once again by the FDA

Last year
FDA+
Manufacturing

Bris­tol My­ers to cut 108 em­ploy­ees in New Jer­sey

Last year
People

FDA pro­mo­tions watch­dog de­liv­ers first warn­ing let­ter of the year to As­traZeneca over Breztri mar­ket­ing

Last year
FDA+
Marketing

Am­i­cus scores an­oth­er ap­proval in the UK for Pompe dis­ease ther­a­py, ex­pects FDA OK in Q3

Last year

Mar­ket­ingRx roundup: Pfiz­er teams with Food Net­work star; Bris­tol My­ers earns 'bil­lion dol­lar' dis­tinc­tion

Last year
Marketing

How Ex­act Sci­ences' out-of-the-box think­ing con­vinced Amer­i­cans to try Co­lo­guard's col­orec­tal can­cer screen­ing test

Last year
Marketing

Re­vance touts first ther­a­peu­tic in­di­ca­tion for Botox ri­val Daxxi­fy in cer­vi­cal dys­to­nia

Last year
FDA+

HHS ham­mers in­dus­try's at­tempt to de­lay new drug price ne­go­ti­a­tions

Last year

Judge strikes down J&J talc unit's sec­ond bank­rupt­cy at­tempt over lack of 'fi­nan­cial dis­tress'

Last year
Law

Am­gen, Hori­zon urge judge to up­hold con­sti­tu­tion­al­i­ty ar­gu­ments against FTC

Last year
Deals

Arc­turus Ther­a­peu­tics hand­ed $115M from Japan­ese gov­ern­ment to de­vel­op pro­duc­tion site

Last year
Manufacturing

Har­mo­ny looks to buy rare dis­ease drug de­vel­op­er in deal worth up to $200M

Last year
Deals

Pfiz­er cel­e­brates ac­cel­er­at­ed win for po­ten­tial mul­ti­ple myelo­ma block­buster

Last year
FDA+

Ra­dius Phar­ma sells off part of its roy­al­ties, mile­stones in breast can­cer drug Orser­du

Last year
Deals

Am­gen takes a light­heart­ed ap­proach in lat­est Ote­zla cam­paign around mild-to-mod­er­ate pso­ri­a­sis

Last year
Marketing

Roivant CEO hints at more deals shap­ing up as key Im­muno­vant da­ta loom

Last year
R&D

Bio­gen's $7.3B deal for Rea­ta fol­lowed a bid­ding war with mys­te­ri­ous 'Par­ty A'

Last year
Deals

FDA hands ap­proval to Janssen's BR­CA-pos­i­tive prostate can­cer com­bo tablet

Last year
FDA+

Supreme Court takes on Pur­due Phar­ma bank­rupt­cy case

Last year
Law

Gilead agrees to pay $247M to set­tle HIV drug case that al­leged com­pe­ti­tion block­ing

Last year
Law

No­vo Nordisk buck­les down on lob­by­ing ef­forts, inch­ing to­ward CMS cov­er­age of obe­si­ty treat­ments

Last year
FDA+

Bris­tol My­ers de­buts cor­po­rate brand ‘an­them’ film on dig­i­tal and so­cial chan­nels, cel­e­brat­ing its sci­ence and peo­ple

Last year
Marketing
First page Previous page 108109110111112113114 Next page Last page
A service from the Financial Times